{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:24:51Z","timestamp":1770348291261,"version":"3.49.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.ijantimicag.2011.04.016","type":"journal-article","created":{"date-parts":[[2011,7,14]],"date-time":"2011-07-14T19:37:08Z","timestamp":1310672228000},"page":"197-216","source":"Crossref","is-referenced-by-count":11,"title":["Trimethoprim\/sulfametrole: evaluation of the available clinical and pharmacokinetic\/pharmacodynamic evidence"],"prefix":"10.1016","volume":"38","author":[{"given":"Evridiki K.","family":"Vouloumanou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drosos E.","family":"Karageorgopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros I.","family":"Rafailidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Argyris","family":"Michalopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E.","family":"Falagas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0005","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA)","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0015","first-page":"60","article-title":"Penicillins vs trimethoprim-based regimens for acute bacterial exacerbations of chronic bronchitis: meta-analysis of randomized controlled trials","volume":"55","author":"Korbila","year":"2009","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0410","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1128\/AAC.01301-08","article-title":"Dosing regimens of cotrimoxazole (trimethoprim\u2013sulfamethoxazole) for melioidosis","volume":"53","author":"Cheng","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(84)80993-2","article-title":"Pseudomonas cepacia infection in cystic fibrosis: an emerging problem","volume":"104","author":"Isles","year":"1984","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0030","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1086\/429730","article-title":"Trimethoprim\u2013sulfamethoxazole in the treatment of Stenotrophomonas maltophilia osteomyelitis","volume":"40","author":"Landrum","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0035","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1473-3099(09)70083-0","article-title":"Stenotrophomonas maltophilia: an emerging opportunist human pathogen","volume":"9","author":"Looney","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0040","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/archotol.131.9.782","article-title":"Trimethoprim\u2013sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children","volume":"131","author":"Al-Shawwa","year":"2005","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0045","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/jac\/dkq478","article-title":"Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint","volume":"66","author":"Lemaire","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0050","first-page":"428","article-title":"Community-associated methicillin-resistant Staphylococcus aureus infections in Israel","volume":"12","author":"Nevet","year":"2010","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/AAC.27.1.71","article-title":"Susceptibility of enterococci to trimethoprim and trimethoprim\u2013sulfamethoxazole","volume":"27","author":"Crider","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0060","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/320532","article-title":"Resistance to trimethoprim\u2013sulfamethoxazole","volume":"32","author":"Huovinen","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0065","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/003655400459577","article-title":"Clinical implications of Stenotrophomonas maltophilia resistant to trimethoprim\u2013sulfamethoxazole: a study of 69 patients at 2 university hospitals","volume":"32","author":"Tsiodras","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijantimicag.2008.09.010","article-title":"Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence","volume":"33","author":"Avgeri","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0075","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jac\/dkn301","article-title":"Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review","volume":"62","author":"Falagas","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0080","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1345\/aph.1D179","article-title":"Adverse reactions to trimethoprim\/sulfamethoxazole in AIDS","volume":"37","author":"Floris-Moore","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0085","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.259.8.1185","article-title":"Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS","volume":"259","author":"Fischl","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0090","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJM199009203231202","article-title":"Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim\u2013sulfamethoxazole versus trimethoprim\u2013dapsone","volume":"323","author":"Medina","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0095","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-109-4-280","article-title":"Trimethoprim\u2013sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study","volume":"109","author":"Sattler","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0100","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199306103282304","article-title":"Cutaneous disease and drug reactions in HIV infection","volume":"328","author":"Coopman","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archinte.145.5.837","article-title":"The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome","volume":"145","author":"Small","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0110","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00007435-198607000-00011","article-title":"Single-dose therapy with trimethoprim\u2013sulfametrole for chancroid in females","volume":"13","author":"Dylewski","year":"1986","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0115","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1056\/NEJM198312293092616","article-title":"Therapy of chancroid with trimethoprim\u2013sulfametrole","volume":"309","author":"Webster","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0120","first-page":"448","article-title":"Pharmacokinetics, tolerance and therapeutic effect of trimethoprim\u2013sulfametrol-infusions (author's transl)","volume":"130","author":"Breyer","year":"1980","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0125","first-page":"388","article-title":"Plasma and renal tissue\u2014concentrations of sulfametrol\u2013trimethoprim following parenteral administration","volume":"101","author":"Friesen","year":"1983","journal-title":"Fortschr Med"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0130","first-page":"310","article-title":"Pharmacokinetics of Lidaprim in cases of impaired renal function","volume":"15","author":"Hitzenberger","year":"1977","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0135","first-page":"169","article-title":"Psychotic reactions after high dose administration of sulfametrol plus trimethoprim","volume":"6","author":"Geit","year":"1997","journal-title":"Chemotherapie J"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0140","first-page":"171","article-title":"Pharmacokinetics of trimethoprim and sulfametrol in patients with end stage renal failure and hemodialysis treatment (author's transl)","volume":"130","author":"Schmidt","year":"1980","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00002030-199603000-00017","article-title":"Cutaneous reactions to trimethoprim\u2013sulphametrole in AIDS patients treated for Pneumocystis carinii pneumonia","volume":"10","author":"van der Ven","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0150","first-page":"12","article-title":"Studies with Lidaprim","author":"Stoegmann","year":"1981","journal-title":"Pediatric Infusions"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0155","first-page":"101","article-title":"Single high dose co-soltrim therapy of uncomplicated acute urinary tract infection","volume":"13","author":"Limson","year":"1984","journal-title":"Philippine J Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0160","first-page":"81","article-title":"Sulfametrol\/trimethoprim (Lidaprim)\u2014modification of the folic acid level and therapeutic value in pediatrics","volume":"129","author":"Borkenstein","year":"1979","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0165","first-page":"611","article-title":"Pharmacokinetic and chemical investigations in children after oral administration of lidaprim (author's transl)","volume":"87","author":"Brandesky","year":"1975","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0170","first-page":"431","article-title":"Treatment of subacute pelvic inflammatory diseases with the antibiotic compound sulfametrol\u2013trimethroprim (author's transl)","volume":"131","author":"Burmucic","year":"1981","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0175","first-page":"313","article-title":"Therapy of the bronchitic syndrome (author's transl)","volume":"87","author":"Danilewicz","year":"1975","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0180","first-page":"32","article-title":"Sulfametrole\u2013trimethoprim in acute pharyngotonsillitis","volume":"2","author":"Martinez-Gallardo","year":"1982","journal-title":"Compend Invest Clin Latinoam"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0185","first-page":"1352","article-title":"Field study: comparative study of co-soltrim and amoxicillin in acute urinary tract infections","volume":"71","author":"Fischer","year":"1982","journal-title":"Schweiz Rundsch Med Prax"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0190","first-page":"252","article-title":"Trimet v amoxycillin in the treatment of otitis media in children","volume":"98","author":"Godfrey","year":"1985","journal-title":"N Z Med J"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0195","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF01647752","article-title":"Antimicrobial chemotherapy in patients with cystic fibrosis","volume":"15","author":"Guggenbichler","year":"1987","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jac\/8.2.133","article-title":"Pharmacokinetics of sulphametrole and its metabolite N4-acetylsulphametrole in man","volume":"8","author":"Hekster","year":"1981","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0399-077X(83)80116-4","article-title":"Trial of trimethoprim plus sulfametrole for treatment of infections in a department of internal medicine","volume":"13","author":"Grolleau","year":"1983","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2008-1062608","article-title":"Treatment of the bacterial prostatitis and pyospermia: concentrations of sulfametrol\/trimethoprim in blood, urine and seminal plasma","volume":"15","author":"Scheiber","year":"1984","journal-title":"Aktuelle Urol"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0215","first-page":"795","article-title":"Treatment of urinary tract infections in paralytics with spinal cord lesions. Effect and tolerance of co-soltrim (lidaprim)","volume":"99","author":"Kisten","year":"1981","journal-title":"Fortschr Med"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0220","first-page":"317","article-title":"Clinical testing of a combination of sulfametrol and trimethoprim (Lidaprim) in urinary tract infections of children","volume":"126","author":"Krepler","year":"1976","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0225","series-title":"American Society of Microbiology Meeting","article-title":"Lidaprim inhibits Pneumocystis carinii in mice","author":"Bartlett","year":"1995"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0230","first-page":"189","article-title":"Treating chancroid with enoxacin","volume":"64","author":"Naamara","year":"1988","journal-title":"Genitourin Med"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0235","first-page":"100","article-title":"Clinical trial of trimethoprim plus sulfametrole in infections in children","volume":"91","author":"Monnet","year":"1984","journal-title":"Gaz Med (Paris)"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0240","first-page":"1773","article-title":"Treatment of chronic urinary infections in a geriatric milieu with co-soltrim","volume":"71","author":"Piguet","year":"1982","journal-title":"Schweiz Rundsch Med Prax"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1056\/NEJM198307143090202","article-title":"Single-dose therapy of chancroid with trimethoprim\u2013sulfametrole","volume":"309","author":"Plummer","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0250","first-page":"508","article-title":"Experience with a combination of sulfametrol and trimethoprim (Lidaprim) in otorhinilaryngologic infections","volume":"125","author":"Steinbock","year":"1975","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0255","first-page":"363","article-title":"Levels of sulfametrole\u2013trimethoprim in blood and lung-tissue during treatment of respiratory tract infection (author's transl)","volume":"131","author":"Wieser","year":"1981","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0260","first-page":"899","article-title":"Treatment of post-partum urinary-tract infection in the young woman by a combination of trimethoprime and sulfametrole","volume":"76","author":"Malinas","year":"1981","journal-title":"Rev Fr Gynecol Obstet"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0265","first-page":"335","article-title":"Tissue concentrations of sulfametrol\u2013trimethoprim in the human prostate (author's transl)","volume":"18","author":"Bergmann","year":"1979","journal-title":"Urologe A"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0270","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/030006058401200316","article-title":"In-vitro comparative study of Lidaprim and co-trimoxazole","volume":"12","author":"Abdel-Messih","year":"1984","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0275","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/clinids\/4.2.411","article-title":"Combination of trimethoprim with sulfonamides other than sulfamethoxazole","volume":"4","author":"Bernstein","year":"1982","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0280","first-page":"103","article-title":"Co-soltrim (lidaprim): microbiological evaluation vs. co-trimoxazole","volume":"2","author":"Scazzocchio","year":"1983","journal-title":"Chemioterapia"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00007435-198301000-00001","article-title":"Antimicrobial therapy of chancroid: an evaluation of five treatment regimens correlated with in vitro sensitivity","volume":"10","author":"Fast","year":"1983","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0290","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000400131","article-title":"Clinical pharmacokinetics of sulphonamides and their N4-acetyl derivatives","volume":"31","author":"Hekster","year":"1982","journal-title":"Antibiot Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0295","first-page":"665","article-title":"Treatment of urinary tract infections with trimethoprim plus sulfametrole. Double blind comparison with co-trimoxazole and sulfametrole","volume":"8","author":"Reynaert","year":"1979","journal-title":"Ars Medici Internationaal Tijdschrift voor Praktische Therapie"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0300","first-page":"276","article-title":"An absence of interaction of sulfametrol\u2013trimethoprim with insulin or sulphonylurea derivatives in diabetics (author's transl)","volume":"92","author":"Kaspar","year":"1980","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0305","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1008617019897","article-title":"Managing drug reactions to sulfonamides and other drugs in HIV infection: desensitization rather than rechallenge?","volume":"20","author":"Koopmans","year":"1998","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0310","first-page":"277","article-title":"Double-blind comparative study of co-trimoxazole and co-soltrim in respiratory tract infections","volume":"2","author":"Luisetti","year":"1983","journal-title":"Chemioterapia"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0315","first-page":"1109","article-title":"Bacteriological study on the chemotherapeutic combination sulfametrole\u2013trimethoprim\/comparison with co-trimoxazole (author's transl)","volume":"27","author":"Nabert-Bock","year":"1977","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0320","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/clpt.2010.74","article-title":"Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide","volume":"88","author":"Schelleman","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0325","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1473-3099(06)70414-5","article-title":"Severe and protracted hypoglycaemia associated with co-trimoxazole use","volume":"6","author":"Strevel","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0330","first-page":"794","article-title":"Differentiation of primary acute and primary chronic interstitial nephritis according to etiological aspects (author's transl)","volume":"130","author":"von Pogglitsch","year":"1980","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0335","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/38.1.75","article-title":"Anti-Toxoplasma effect of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapy","volume":"38","author":"van der Ven","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0340","volume":"vol. 37","author":"Vree","year":"1987"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0345","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/00048678709160931","article-title":"Requests for psychiatric consultation concerning 22 patients with AIDS and ARC","volume":"21","author":"Buhrich","year":"1987","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001504-198902000-00002","article-title":"Psychotic states in human immunodeficiency virus illness","volume":"2","author":"Busch","year":"1989","journal-title":"Curr Opin Psychiatr"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0355","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/clinids\/20.6.1563","article-title":"Clarithromycin-induced mania in two patients with AIDS","volume":"20","author":"Nightingale","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"Suppl. B","key":"10.1016\/j.ijantimicag.2011.04.016_bib0360","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jac\/37.suppl_B.55","article-title":"Adverse reactions to co-trimoxazole in HIV infection: a reappraisal of the glutathione-hydroxylamine hypothesis","volume":"37","author":"van der Ven","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0365","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/875512259501100607","article-title":"Apparent hemolysis in an AIDS patient receiving trimethoprim\/sulfamethoxazole: case report and literature review","volume":"11","author":"Reinke","year":"1996","journal-title":"J Pharm Technol"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0370","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1096\/fasebj.13.13.1688","article-title":"Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole","volume":"13","author":"Hess","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0375","doi-asserted-by":"crossref","unstructured":"What are excipients doing in medicinal products? Drug Ther Bull 2009;47:81\u20134.","DOI":"10.1136\/dtb.2009.06.0026"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0380","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.aan.2008.07.010","article-title":"Unapproved paediatric drugs: evidence for use","volume":"26","author":"Tobias","year":"2008","journal-title":"Advances in Anesthesia"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0385","first-page":"529","article-title":"Excipients, adverse drug reactions and patients\u2019 rights","volume":"151","author":"Napke","year":"1994","journal-title":"CMAJ"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0390","doi-asserted-by":"crossref","first-page":"F236","DOI":"10.1136\/adc.2008.146035","article-title":"Toxic additives in medication for preterm infants","volume":"94","author":"Whittaker","year":"2009","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0395","first-page":"48","article-title":"Hulpstoffen in geneesmiddelen voor kinderen: functies en toxiciteit Farmacotherapie bij kinderen","volume":"2","author":"Lagas-de-Graaf","year":"2009","journal-title":"Farmacotherapie bij kinderen"},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0400","unstructured":"Rokiprim\u00ae. Summary of product characteristics. Vienna, Austria: Rokitan GmbH."},{"key":"10.1016\/j.ijantimicag.2011.04.016_bib0405","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1179\/joc.2009.21.2.115","article-title":"Trimethoprim\u2013sulfamethoxazole for methicillin-resistant Staphylococcus aureus: a forgotten alternative?","volume":"21","author":"Pappas","year":"2009","journal-title":"J Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911002172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911002172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:19:43Z","timestamp":1560385183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857911002172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0924857911002172"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.04.016","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}